» Articles » PMID: 33758364

Double Insult: Flu Bug Enhances SARS-CoV-2 Infectivity

Overview
Journal Cell Res
Specialty Cell Biology
Date 2021 Mar 24
PMID 33758364
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Respiratory Pathogen Coinfection During Intersecting COVID-19 and Influenza Epidemics.

Jiang L, Jin Y, Li J, Zhang R, Zhang Y, Cheng H Pathogens. 2025; 13(12.

PMID: 39770372 PMC: 11678382. DOI: 10.3390/pathogens13121113.


Analysis of spatial and temporal aggregation of influenza cases in Quzhou before and after COVID-19 pandemic.

Gao Q, Yang H, Yu Z, Wang Q, Wang S, Zhan B Ann Med. 2024; 57(1):2443565.

PMID: 39711429 PMC: 11703302. DOI: 10.1080/07853890.2024.2443565.


2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.

Bozkurt B, Das S, Addison D, Gupta A, Jneid H, Khan S J Am Coll Cardiol. 2022; 80(4):388-465.

PMID: 35753858 PMC: 9222652. DOI: 10.1016/j.jacc.2022.03.355.


2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.

Bozkurt B, Das S, Addison D, Gupta A, Jneid H, Khan S Circ Cardiovasc Qual Outcomes. 2022; 15(7):e000111.

PMID: 35737748 PMC: 9297692. DOI: 10.1161/HCQ.0000000000000111.


Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid?.

Liu S, Li W, Jiang S J Med Virol. 2022; 94(9):4056-4057.

PMID: 35590473 PMC: 9348440. DOI: 10.1002/jmv.27874.

References
1.
Ziegler C, Allon S, Nyquist S, Mbano I, Miao V, Tzouanas C . SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020; 181(5):1016-1035.e19. PMC: 7252096. DOI: 10.1016/j.cell.2020.04.035. View

2.
Liu Z, Xu W, Xia S, Gu C, Wang X, Wang Q . RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020; 5(1):282. PMC: 7691975. DOI: 10.1038/s41392-020-00402-5. View

3.
Lavine J, Bjornstad O, Antia R . Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021; 371(6530):741-745. PMC: 7932103. DOI: 10.1126/science.abe6522. View